You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Massively-Parallel Sequencing

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Search for New Genetic Causes of Hypercalcemia by Massively

Completed
  • Hypercalcemia
  • genetic analysis with massively parallel sequencing
  • Caen, France
    Caen Hospital University
Jul 27, 2021

Non-Immune Hydrops Fetalis Trial in France (NON-IMMUNE HYDROPS FETALIS diagnosis)

Recruiting
  • Non-Immune Hydrops Fetalis
  • NON-IMMUNE HYDROPS FETALIS diagnosis
  • Besançon, France
  • +16 more
Jan 17, 2022

Breast Cancer, Colo-rectal Cancer Trial in Avignon (Blood samples)

Recruiting
  • Breast Cancer
  • Colo-rectal Cancer
  • Blood samples
  • Avignon, France
    Centre Hospitalier Henri Duffaut
Jan 8, 2021

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Genetic Bases of COVID-19 Clinical Variability

Recruiting
  • COVID-19
  • Massive parallel sequencing of host genome
  • Siena, Italy
    University of Siena
Nov 3, 2022

Genes Contributing to Hereditary Ovarian Cancer in Women and

Completed
  • Ovarian Cancer
    • Seattle, Washington
      University of Washington
    Feb 2, 2022

    Clinical Performance of NIPT in Multiple Gestation Pregnancies

    Active, not recruiting
    • Trisomy 21 in Fetus
    • MaterniT21 PLUS and GENOME Laboratory-Developed Tests
    • Philadelphia, Pennsylvania
      University of Pennsylvania
    Dec 1, 2021

    Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Jan 24, 2023

    Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)

    Recruiting
    • Adenocarcinoma
    • +75 more
    • Biomarker Testing (L)
    • +2 more
    • Idaho Falls, Idaho
    • +1 more
    Oct 18, 2022

    Stage, Colon Cancer, Stage I-III Colon Cancer, Stage IV Colon Cancer With Resectable Liver Metastases Trial in Boston (Vitamin

    Recruiting
    • Stage, Colon Cancer
    • +2 more
    • Vitamin D3
    • Placebo
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    May 18, 2022

    Solid Tumor, FGF Receptor Gene Mutation, FGF Amplification Trial in Tianjin (Pemigatinib)

    Recruiting
    • Solid Tumor
    • +4 more
    • Tianjin, Tianjin, China
      Tianjin Medical University Second Hospital
    Aug 28, 2023

    Technological Development and Clinical Parallel Testing of PGT-G

    Not yet recruiting
    • Genetic Disease
      • (no location specified)
      Nov 7, 2022

      Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)

      Completed
      • Neurofibromatosis
      • MPNST
      • MRI, FDG-PET/CT scans
      • [18F]-FLT-PET/CT scans
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Crizotinib - Usual
      • Crizotinib - Study
      • Rockville, Maryland
        Medicine Invention Design, Inc. - IORG0007849
      Aug 15, 2023

      NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • Crizotinib - Usual
      • Crizotinib - Study
      • Rockville, Maryland
        Medicine Invention Design, Inc. - IORG0007849
      Oct 5, 2023

      Soft Tissue Sarcoma Trial in France (drug, combination product, other)

      Recruiting
      • Soft Tissue Sarcoma
      • Bordeaux, France
      • +17 more
      Oct 4, 2022

      Prognosis in Resected Pancreatic Cancer Using Organoid

      Recruiting
      • Pancreatic Cancer Resectable
      • Organoid
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jan 29, 2021

      Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Israel (ixazomib-pomalidomide-dexamethasone)

      Recruiting
      • Multiple Myeloma in Relapse
      • Refractory Multiple Myeloma
      • Afula, Israel
      • +7 more
      Jul 10, 2022

      Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

      Not yet recruiting
      • Genetic Predisposition
      • Next-Generation Sequencing (NGS)
      • Tübingen, Germany
        University Hospital Tübingen
      Sep 22, 2023

      Effects of Cerebellar Stimulation on Brain Activation Trial in Baltimore (TMS during sequence-demanding task, No TMS during

      Not yet recruiting
      • Effects of Cerebellar Stimulation on Brain Activation
      • TMS during sequence-demanding task
      • +3 more
      • Baltimore, Maryland
        Johns Hopkins University School of Medicine
      Oct 25, 2023

      Kinase Inhibitors Based on Protein Phosphorylation Profiles in

      Terminated
      • Renal Cell Cancer
        • Amsterdam, Noord Holland, Netherlands
          VU Medical Center
        Nov 18, 2020

        Classical Lissencephalies and Subcortical Band Heterotopias Trial in Jette (Venipuncture and skin biopsy for RNA extraction)

        Not yet recruiting
        • Classical Lissencephalies and Subcortical Band Heterotopias
        • Venipuncture and skin biopsy for RNA extraction
        • Jette, Brussel, Belgium
          UZ Brussel
        Jan 7, 2022

        Four Common Cancers Using the ctDNA Analysing Test

        Recruiting
        • Cancer, Lung
        • +6 more
          • Hanoi, Vietnam
            Hanoi medical university
          Nov 23, 2022

          Whole Exome Sequencing, Epileptic Encephalopathy Trial in Ho Chi Minh city

          Recruiting
          • Whole Exome Sequencing
          • Epileptic Encephalopathy
            • Ho Chi Minh city, Ho Chi Minh, Vietnam
              N02 Children's Hospital
            Feb 1, 2023

            Breast Cancer Trial in Brazil (Docetaxel or Paclitaxel, Cyclophosphamide + Doxorrubicin)

            Recruiting
            • Breast Cancer
            • Docetaxel or Paclitaxel
            • Cyclophosphamide + Doxorrubicin
            • Goiânia, Goiás, Brazil
            • +9 more
            Jan 5, 2023